Cargando…
MON-LB83 The Initial Dose of (131)I as a Potential Independent Predictor for Residual/Relapsed Disease in Pediatric Differentiated Thyroid Cancer
Introduction: In the guidelines for management of pediatric Differentiated Thyroid Cancer (DTC) (131)I therapy is recommended for treatment of iodine-avid persistent locoregional disease that cannot be resected as well as iodine-avid distant metastases. To date, no consensus has been reached regardi...
Autores principales: | Bustamante Escobar, Carmen L, Bao, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209508/ http://dx.doi.org/10.1210/jendso/bvaa046.2179 |
Ejemplares similares
-
MON-LB095 Thyroid Nodule Localization as a Predictor Factor for Malignancy
por: Sibai, Zakaria, et al.
Publicado: (2019) -
MON-LB75 Stratifying the Risk of Malignancy in Indeterminate Thyroid Nodules
por: Imam, Shahnawaz, et al.
Publicado: (2020) -
MON-LB101 Pharmacokinetics of Liothyronine during Thyroid Hormone Therapy Withdrawal
por: Celi, Francesco, et al.
Publicado: (2019) -
MON-LB77 Inhibitors of XIAP as Novel Therapeutic Agents in Thyroid Cancer
por: Chu, Simon, et al.
Publicado: (2020) -
MON-LB78 Thyroid Nodules > 4cm: High-Risk for Malignancy or Not?
por: Fishel, Heather, et al.
Publicado: (2020)